Rapid-Acting Insulin Analogues: Trials Provide No Proof Of Additional Benefit For Children And Adolescents With Type 1 Diabetes

Long-term research is lacking – potential harm remains unclear – valid studies are urgently needed for growing and developing children and adolescents Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term treatment with rapid-acting insulin analogues than with short-acting human insulin. Certainly, there is no proof of additional benefit from the available results from clinical trials of maximum one year duration…

Read more from the original source: 
Rapid-Acting Insulin Analogues: Trials Provide No Proof Of Additional Benefit For Children And Adolescents With Type 1 Diabetes

Related posts:

1. Cardiovascular Risk In Youth With Type 1 Diabetes Linked Primarily To Insulin Resistance According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), youth with type 1 diabetes have now been found to have...
2. Biovitrum Advances Novel Factor VIII Long-Acting Hemophilia A Therapy Into Clinical Trials Biovitrum AB (publ) (STO: BVT) announced that the first patient was dosed in a phase I/IIa study of its long-acting fully-recombinant Factor VIII Fc fusion (rFVIIIFc) protein. The phase I/IIa...
3. Type 2 Diabetes Gene Predisposes Children To Obesity Pediatric researchers have found that a gene already implicated in the development of type 2 diabetes in adults also raises the risk of being overweight during childhood. The finding sheds...
4. Risk For Obstructive Sleep Apnea Increased By Obesity In Adolescents, But Not In Younger Children A study in the Dec. 15 issue of the Journal of Clinical Sleep Medicine shows that being overweight or obese increases the risk for developing obstructive sleep apnea (OSA) in...
5. UNC Scientists Coordinate Study To Determine Link Between Insulin Use And Cancer In People With Diabetes Type 2 diabetes and obesity are linked to an increased risk of certain cancers. Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name...
6. Four New Research Projects Announced – Diabetes UK Diabetes UK has dedicated almost £750,000 to four new research projects looking to understand the causes of diabetes, help with its day-to-day management and protect against its complications. All four...
7. Echo Therapeutics Announces Positive Results Of A Clinical Study Testing Symphony(TM) TCGM System In Patients With Type 1 And Type 2 Diabetes Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System...
8. FDA Approved Drug May Slow Beta Cell Destruction In Type 1 Diabetes Patients New findings by UT Southwestern researchers suggest that a drug already used to treat autoimmune disorders might also help slow the destruction of insulin-producing cells in patients recently diagnosed with...
9. New Type 2 Diabetes And Obesity Treatment Approved – EndoBarrier Receives European CE Mark GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier(TM), a non-surgical therapy...
10. Stay-Tabs On Beverage Cans Pose Swallowing Risk To Children And Adolescents Three decades ago, a study revealed that beverage can pull-tabs were being swallowed by children, prompting a switch by U.S. manufacturers to stay-tabs. But a study presented at the annual...
11. Two Thirds Of Brits Do Not Know The Difference Between Type 1 And Type 2 Diabetes New research out today reveals that less than a third of UK residents (30 per cent) know of type 1 diabetes with a further 59 per cent confusing the autoimmune...
12. Discovery Of Mechanism Of Insulin Production May Lead To Better Treatment For Diabetes How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem, in collaboration with Japanese and American universities. Their...
13. FAQs About Type 2 Diabetes Cure Have you just been diagnosed with type 2 diabetes? Are you looking for a type 2 diabetes cure? Find out the truth about type 2 diabetes cure....
14. OssulinTM, A Novel Oral Insulin Product, Shows Promising Bioavailability For Advancing Diabetes Therapy New data from Puredel Limited, presented at the 9th Annual Diabetes Technology Meeting in San Francisco, CA, suggests that higher blood levels of insulin were achieved by Ossulin™ than had...
15. What is the history and Origin of Type 2 Diabetes? Diabetes has been one of the most shattering diseases known to man, and it has been acknowledged for over two thousand years, but there is no account of type 2...

« Electronic Cigarettes Let You Light Up When You Want To Specific Problems Among Youth And Young Adults Due To Alcohol Outlets »